Long-Term Survival In Premenopausal Women With Early Breast Cancer Improved By Goserelin

News — By on February 25, 2009 at 6:00 am

Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, according to trial data reported in the February 24 online issue of the Journal of the National Cancer Institute.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback